TScan Therapeutics CEO Gavin MacBeath's 2023 pay jumps 135% to $3.2M
TScan Therapeutics reports 2023 executive compensation
By ExecPay News
Published: April 30, 2024
TScan Therapeutics reported fiscal year 2023 executive compensation information on April 30, 2024.
In 2023, five executives at TScan Therapeutics received on average a compensation package of $1.9M, a 10% increase compared to previous year.
Average pay of disclosed executives at TScan Therapeutics
Gavin MacBeath, Chief Executive Officer, received $3.2M in total, which increased by 135% compared to 2022. 73% of MacBeath's compensation, or $2.3M, was in option awards. MacBeath also received $296K in non-equity incentive plan, $545K in salary, as well as $12K in other compensation.
Debora Barton, Chief Medical Officer, received a compensation package of $1.7M. 55% of the compensation package, or $945K, was in option awards.
Brian Silver, Chief Financial Officer, earned $1.6M in 2023, a 1% decrease compared to previous year.
Zoran Zdraveski, Secretary, received $1.6M in 2023.
David Southwell, Chief Executive Officer, earned $1.3M in 2023, a 40% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 30, 2024.